Does anticoagulant therapy improve pregnancy outcome equally, regardless of specific thrombophilia type?

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 2, 2014, Pages 184-189

  Kovac, Mirjana ^a,b   Mikovic, Zeljko ^c   Mitic, Gorana ^d   Djordjevic, Valentina ^c   Mandic, Vesna ^c   Rakicevic, Ljiljana ^c   Radojkovic, Dragica ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Blood Transfusion Institute of Serbia   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

inherited thrombophilia; low molecular weight heparin; pregnancy outcome

Indexed keywords

NADROPARIN;

ANTICOAGULANT THERAPY; ARTICLE; FETUS DEATH; FETUS WASTAGE; INTRAUTERINE GROWTH RETARDATION; LIVE BIRTH; POSTPARTUM THROMBOSIS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECURRENT FETAL LOSS; THROMBOPHILIA; THROMBOSIS;

INHERITED THROMBOPHILIA; LOW-MOLECULAR-WEIGHT HEPARIN; PREGNANCY OUTCOME;

ADULT; ANTICOAGULANTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84893439242     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612468940     Document Type: Article

References (28)

1. Regan I, Rai R. Epidemiology of the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 ; 14 (5). 839-854
2. Sanson BJ, Friederich PW, Simoni P, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost. 1996 ; 75 (3). 387-388
3. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: meta analysis. Lancet. 2003 ; 361 (9361). 901-908
4. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: systematic review. Br J Haematol. 2006 ; 132 (2). 171-196
5. Kovac M, Mitic G, Mikovic Z, et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy related venous thromboembolism. Gynecol Obstet Invest. 2010 ; 69 (4). 233-238
6. Mitic G, Kovac M, Povazan L, et al. Inherited thrombophilia is associated with pregnancy losses that occur after 12th gestational week in Serbian population. Clin Appl Thromb Hemost. 2010 ; 16 (4). 435-439
7. Clark P, Greer IA, Walker I. Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy. Blood Rev. 1999 ; 13 (3). 127-146
8. Girardi G, Rdecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004 ; 10 (11). 1222-1226
9. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 2000 ; 83 (5). 693-697
10. Brenner B, Hoffman R, Carp H, Dulitzky M, Younis JS. Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005 ; 3 (2). 227-229
11. Carp H, Dulitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost. 2003 ; 1 (3). 433-438
12. Gris JC, Mercier E, Quere I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004 ; 103 (10). 3695-3699
13. Lindqvist PG, Merlo J. The natural course of women with recurrent fetal loss. J Thromb Haemost. 2006 ; 4 (4). 896-897
14. Mantha S, Bauer K, Zwicker JI. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost. 2010 ; 8 (2). 263-268
15. Visser J, Ulander VM, Helmerhorst FM, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia HABENOX: a randomised multicentre trial. Thromb Haemost. 2011 ; 105 (2). 295-301
16. Clark P, Walker ID, Langhorne P, et al. SPIN: the Scottish Pregnancy Intervention Study: a multicentre randomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage. Blood. 2010 ; 115 (21). 4162-4167
17. Kovac M, Mikovic Z, Rakicevic LJ, et al. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obst Gynecol Reprod Biol. 2010 ; 148 (1). 27-30
18. Farguharson RG, Jauniaux E, Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod. 2005 ; 20 (11). 3008-3011
19. Intrauterine Growth Restriction. Washington DC: AOCG ;
20. Sarto A, Rocha M, Geller M. Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia [in Spanish]. Medicina (B Aires). 2001 ; 61 (4). 406-412
21. Monien S, Kadecki O, Baumgarten S, Salama A, Dorner T, Kieswetter IH. Use of heparin in women with early and late miscarriage with and withot thrombophilia. Clin Appl Thromb Hemost. 2009 ; 15 (6). 636-644
22. Sabadell J, Casellas M, Alijotas-Reig J, Arellano-Rodrigo E, Cabero L. Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol. 2009 ; 149 (1). 47-51
23. Folkeringa N, Brouwer JL, Korteweg FJ, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007 ; 136 (4). 656-661
24. Grandone E, DeStefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis. 2008 ; 19 (3). 226-230
25. Sarig G, Blumenfeld Z, Leiba R, Lanir N, Brenner B. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss. Thromb Haemost. 2005 ; 94 (5). 980-985
26. Abou-Nassar K, Kovacs M, Kahn S, et al. TIPPS investigators: the effect of deltaparin on coagulation activation during pregnancy in women with thrombophilia. Thromb Haemost. 2007 ; 98 (1). 163-171
27. Eichinger S, Waltermann A, Phillip K, et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without Factor V Leiden. Thromb Haemost. 1999 ; 82 (4). 1232-1236
28. Hoke M, Kyrle PA, Phillip K, et al. Prospective evaluation of coagulation activation in pregnant women reciving low-molecular weight heparin. Thromb Haemost. 2004 ; 91 (5). 935-940